Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-001030
Filing Date
2020-01-03
Accepted
2020-01-03 18:16:17
Documents
1
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3383
  Complete submission text file 0001104659-20-001030.txt   4733
Mailing Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Issuer) CIK: 0001744659 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AKERO THERAPEUTICS INC. 170 HARBOR WAY 3RD FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address
Yale Catriona (Reporting) CIK: 0001779308 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38944 | Film No.: 20507328